Condition: Breast Cancer · Cancer · Sponsor: Sidekick Health
This is a randomized, controlled study to assess the effect of Sidekick Health's digital program on self-efficacy and medication adherence in breast cancer patients prescribed adjuvant anti-hormonal treatment. Participants will be treated with the digital program in addition to standard of care (SoC), or SoC only.
This description comes directly from the study's public registry record.
Sigridur Lara Gudmundsdottir, PhD · +3546114475 · siggalara@sidekickhealth.com
Always discuss trial participation with your own doctor first.
| Landspitali University Hospital | Reykjavik, Iceland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06989450